Baclofen
NDC Package 50090-0564-3

11-digit billing NDC: 50090056403

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Baclofen is tablets are useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity.Patients should have reversible spasticity so that baclofen treatment will aid in restoring residual function. Marketed by A-s Medication Solutions, this product is identified by NDC 50090-0564 and is authorized under FDA application ANDA072234.

Identification & Billing

NDC Package Code
50090-0564-3
Package Description
90 TABLET in 1 BOTTLE
Product Code
11-Digit Billing Format
50090056403
RxNorm Crosswalk
RxCUI: 197391 - baclofen 10 MG Oral Tablet

Clinical Specifications

Proprietary Name
Baclofen
Dosage Form
-
Usage Information
Baclofen tablets are useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity.Patients should have reversible spasticity so that baclofen treatment will aid in restoring residual function. Baclofen tablets may also be of some value in patients with spinal cord injuries and other spinal cord diseases. Baclofen tablets are not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders. The efficacy of baclofen in stroke, cerebral palsy, and Parkinson’s disease has not been established and, therefore, it is not recommended for these conditions.

Regulatory & Marketing

Labeler Name
A-s Medication Solutions
FDA Application #
ANDA072234
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-21-1988
Listing Expiration
12-31-2022
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (50090-0564). Click a package code to view its specific billing and regulatory data.

60 TABLET in 1 BOTTLE
30 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50090-0564-3 identifies a specific commercial package of 90 tablet in 1 bottle of Baclofen, labeled by A-s Medication Solutions. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by A-s Medication Solutions on July 21, 1988. The current certification is valid through December 31, 2022.

How is this A-s Medication Solutions product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50090056403. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
50090-0564-3
11-Digit CMS (5-4-2)
50090-0564-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.